Henry Schein Partners With IMF And LUGPA To Raise Awareness Of The Critical Role Early Detection Plays In The Fight Against Prostate Cancer

MELVILLE, N.Y., Aug. 31, 2017

The American Cancer Society expects more than 160,000 men to be diagnosed with prostate cancer and more than 26,000 men to die from the disease in 2017. A leading cause of death in men, the National Cancer Institute estimates that approximately one in nine men will be diagnosed with prostate cancer in their lifetime.

"We have seen time and time again that early detection of prostate cancer greatly enhances a patient's chances of beating the disease, so it is incumbent upon each of us in the health care community to communicate the importance of prostate cancer screenings to our patients and their families," said Dr. Deepak A. Kapoor, President, Advanced Urology Centers of New York, and Clinical Associate Professor of Urology at the Icahn School of Medicine at Mount Sinai. "Prostate cancer is a curable cancer when caught early, and we must do all we can to ensure that we catch every case in time."

In honor of the observance, Henry Schein will support IMF and LUGPA with a series of communication efforts to heighten awareness among practitioners and the public about the importance of early detection in the fight against prostate cancer. Strategies include the distribution of educational materials to practitioners, as well as a public service announcement and the airing of an educational prostate cancer awareness video on the Nasdaq Tower in Times Square, located in New York City.

"Prostate cancer is a health issue that affects anyone with a father or son, a brother or grandfather, and we at Henry Schein are pleased to partner with IMF and LUGPA in raising awareness of the importance of early detection," said Bridget Ross, President, Global Medical Group, Henry Schein. "One simple test could make all the difference, and Prostate Cancer Awareness Month presents a great opportunity for medical practitioners to speak with their patients about whether a prostate cancer screening is right for them."

About Integrated Medical Foundation, Inc.  
Integrated Medical Foundation is a 50l(c)(3) organization which promotes awareness and early detection of prostate cancer. Integrated Medical Foundation is committed to improving patient healthcare through education and outreach, offering free programs, free support services, and free prostate cancer screenings to the community. For more information, visit www.imfcares.org.

About LUGPA 
LUGPA is a trade Association that represents independent urology group practices in the U.S., with more than 2,200 physicians who make up more than 25 percent of the nation's practicing urologists, and provide more than 30 percent of the total urologic care in the U.S. The association is committed to providing the best resources and information for its member practices through advocacy, research, data collection and benchmarking efforts. LUGPA advocates for independent urology practices by promoting quality clinical outcomes, fostering new opportunities and improving advocacy in the legislative and regulatory arenas. For more information, visit www.lugpa.org.